<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45350">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02069626</url>
  </required_header>
  <id_info>
    <org_study_id>2013/214</org_study_id>
    <nct_id>NCT02069626</nct_id>
  </id_info>
  <brief_title>The Effect of Compression Time for Secure Stapling With a Linear Stapler in Laparoscopic Gastric Bypass Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inonu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inonu University</source>
  <oversight_info>
    <authority>Turkey: Drug and Medical Device Institution</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bleeding from the staple line is a complication of linear stapling. After clamping, a short
      period after firing of the laparoscopic linear stapler is recommended. That is, the
      clinician should continue to press the tissue between the prongs of the device to achieve
      adequate hemostasis at the staple line. The significance of the waiting period for
      hemostasis at the staple line has not been empirically clarified in humans. In this study,
      the investigators compared the number of bleeding points use of the laparoscopic linear
      stapler. Consequently, the investigators assessed the effects of time after the firing of
      linear stapling in patients who underwent laparoscopic gastric bypass.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Number of the bleeding points at the staple line</measure>
    <time_frame>intraoperative</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Bleeding of the Staple Line</condition>
  <arm_group>
    <arm_group_label>No wait</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usage of linear stapler without waiting of compression time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20 second wait</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usage of linear stapler with 20 second compression time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>60 second wait</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usage of linear stapler with 60 second compression time</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>compression time of the laparoscopic linear stapler</intervention_name>
    <arm_group_label>No wait</arm_group_label>
    <arm_group_label>20 second wait</arm_group_label>
    <arm_group_label>60 second wait</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of morbid obesity

          -  Must be laparoscopic surgery

        Exclusion Criteria:

          -  Usage of anti-coagulant

          -  Presence of impaired blood clotting
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Turgut Ã–zal medical center</name>
      <address>
        <city>Malatya</city>
        <zip>44000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 21, 2014</lastchanged_date>
  <firstreceived_date>February 18, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inonu University</investigator_affiliation>
    <investigator_full_name>mehmet ali yagci</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
